These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 15075077)

  • 1. Cytotoxic CD4+ T cells in patients with B cell chronic lymphocytic leukemia kill via a perforin-mediated pathway.
    Porakishvili N; Kardava L; Jewell AP; Yong K; Glennie MJ; Akbar A; Lydyard PM
    Haematologica; 2004 Apr; 89(4):435-43. PubMed ID: 15075077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human purified protein derivative-specific CD4+ T cells use both CD95-dependent and CD95-independent cytolytic mechanisms.
    Lewinsohn DM; Bement TT; Xu J; Lynch DH; Grabstein KH; Reed SG; Alderson MR
    J Immunol; 1998 Mar; 160(5):2374-9. PubMed ID: 9498779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura.
    Zhang F; Chu X; Wang L; Zhu Y; Li L; Ma D; Peng J; Hou M
    Eur J Haematol; 2006 May; 76(5):427-31. PubMed ID: 16480433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand.
    Miura Y; Thoburn CJ; Bright EC; Hess AD
    Biol Blood Marrow Transplant; 2004 Mar; 10(3):156-70. PubMed ID: 14993881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo.
    Di Ianni M; Moretti L; Terenzi A; Bazzucchi F; Del Papa B; Bazzucchi M; Ciurnelli R; Lucchesi A; Sportoletti P; Rosati E; Marconi PF; Falzetti F; Tabilio A
    Cytotherapy; 2009; 11(1):86-96. PubMed ID: 19153855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential utilization of the perforin/granzyme pathway for lysis of Epstein-Barr virus-transformed lymphoblastoid cells by virus-specific CD4+ T cells.
    Khanolkar A; Yagita H; Cannon MJ
    Virology; 2001 Aug; 287(1):79-88. PubMed ID: 11504544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal expansion within the CD4+CD57+ and CD8+CD57+ T cell subsets in chronic lymphocytic leukemia.
    Serrano D; Monteiro J; Allen SL; Kolitz J; Schulman P; Lichtman SM; Buchbinder A; Vinciguerra VP; Chiorazzi N; Gregersen PK
    J Immunol; 1997 Feb; 158(3):1482-9. PubMed ID: 9013995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.
    Bojarska-Junak A; Rolinski J; Wasik-Szczepaneko E; Kaluzny Z; Dmoszynska A
    Haematologica; 2002 May; 87(5):490-9. PubMed ID: 12010662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of intracellular IL-2, TNF-alpha, and IFN-gamma by T cells in B-CLL.
    Gallego A; Vargas JA; Castejón R; Citores MJ; Romero Y; Millán I; Durántez A
    Cytometry B Clin Cytom; 2003 Nov; 56(1):23-9. PubMed ID: 14582134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL.
    Lee SH; Bar-Haim E; Machlenkin A; Goldberger O; Volovitz I; Vadai E; Tzehoval E; Eisenbach L
    Cancer Gene Ther; 2004 Mar; 11(3):237-48. PubMed ID: 14739939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
    Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS
    Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutting edge: CD4+ T cells kill CD8+ T cells via Fas/Fas ligand-mediated apoptosis.
    Piazza C; Gilardini Montani MS; Moretti S; Cundari E; Piccolella E
    J Immunol; 1997 Feb; 158(4):1503-6. PubMed ID: 9029083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
    Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF
    Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic mechanisms in different forms of T-cell-mediated drug allergies.
    Kuechler PC; Britschgi M; Schmid S; Hari Y; Grabscheid B; Pichler WJ
    Allergy; 2004 Jun; 59(6):613-22. PubMed ID: 15147446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of CD28 and CTLA-4 expression by CD4 T cells from previously immunodeficient HIV-infected patients with sustained virological responses to highly active antiretroviral therapy.
    Stone SF; Price P; French MA
    HIV Med; 2005 Jul; 6(4):278-83. PubMed ID: 16011533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superantigen-driven, CD8+ T cell-mediated down-regulation: CD95 (Fas)-dependent down-regulation of human Ig responses despite CD95-independent killing of activated B cells.
    Stohl W; Lynch DH; Starling GC; Kiener PA
    J Immunol; 1998 Oct; 161(7):3292-8. PubMed ID: 9759844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional subsets of CD4 T cells in rheumatoid synovitis.
    Namekawa T; Wagner UG; Goronzy JJ; Weyand CM
    Arthritis Rheum; 1998 Dec; 41(12):2108-16. PubMed ID: 9870867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells.
    Secchiero P; Tiribelli M; Barbarotto E; Celeghini C; Michelutti A; Masolini P; Fanin R; Zauli G
    J Cell Physiol; 2005 Nov; 205(2):246-52. PubMed ID: 15887227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible role of Fas/Fas ligand-mediated apoptosis in the pathogenesis of fixed drug eruption.
    Choi HJ; Ku JK; Kim MY; Kang H; Cho SH; Kim HO; Park YM
    Br J Dermatol; 2006 Mar; 154(3):419-25. PubMed ID: 16445769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.